CSF cutoffs for MCI due to AD depend on APOEε4 carrier status-Reference-Cited by-同舟云学术

CSF cutoffs for MCI due to AD depend on APOEε4 carrier status

Published:2020-05 Issue: Volume:89 Page:55-62
ISSN:0197-4580
Container-title:Neurobiology of Aging
language:en
Short-container-title:Neurobiology of Aging

Author:

Marizzoni Moira^ORCID,Ferrari Clarissa,Babiloni Claudio^ORCID,Albani Diego^ORCID,Barkhof Frederik,Cavaliere Libera,Didic Mira,Forloni Gianluigi,Fusco Federica,Galluzzi Samantha,Hensch Tilman,Jovicich Jorge^ORCID,Marra Camillo,Molinuevo José Luis,Nobili Flavio^ORCID,Parnetti Lucilla,Payoux Pierre,Ranjeva Jean-Philippe^ORCID,Ribaldi Federica,Rolandi Elena,Rossini Paolo Maria,Salvatore Marco,Soricelli Andrea,Tsolaki Magda,Visser Pieter Jelle^ORCID,Wiltfang Jens^ORCID,Richardson Jill C.,Bordet Régis,Blin Olivier,Frisoni Giovanni B.^ORCID

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Developmental Biology,Neurology (clinical),Aging,General Neuroscience

Reference51 articles.

1. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease;Albert;Alzheimers Dement.,2011

2. Sex modifies the APOE-related risk of developing Alzheimer disease;Altmann;Ann. Neurol.,2014

3. Apolipoprotein E4 causes age- and tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice;Andrews-Zwilling;J. Neurosci.,2010

4. Determining cut-points for Alzheimer’s disease biomarkers: statistical issues, methods and challenges;Bartlett;Biomark. Med.,2012

5. Unbiased estimates of cerebrospinal fluid beta-amyloid 1-42 cutoffs in a large memory clinic population;Bertens;Alzheimers Res. Ther.,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unsupervised [18F]Flortaucipir cutoffs for tau positivity and staging in Alzheimer’s disease;European Journal of Nuclear Medicine and Molecular Imaging;2023-06-05

2. Alzheimer’s disease: a scoping review of biomarker research and development for effective disease diagnosis;Expert Review of Molecular Diagnostics;2022-07-03

3. Establishment of combined diagnostic models of Alzheimer’s disease in a Chinese cohort: the Chongqing Ageing & Dementia Study (CADS);Translational Psychiatry;2022-06-16

4. CSF and Plasma Cholinergic Markers in Patients With Cognitive Impairment;Frontiers in Aging Neuroscience;2021-08-26

5. Memory Clinics and Day Care Centers in Thessaloniki, Northern Greece: 30 Years of Clinical Practice and Experience;Frontiers in Neurology;2021-08-25